missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18560269

KIR3DL2/CD158k Antibody (539304), DyLight 350, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals FAB2878D

533.80 EUR valid until 2025-12-16
BEST PRICE on Promo! Use promo code "24090" to get your promotional price.

Product Code. 18560269

  • 670.00 € / 0.10mL
Define Immunology Research on Your Terms With R&D Systems
Use promo code 24090
View all promotions

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

KIR3DL2/CD158k Monoclonal antibody specifically detects KIR3DL2/CD158k in Human samples. It is validated for Flow Cytometry, CyTOF
TRUSTED_SUSTAINABILITY
Specifications

Specifications

KIR3DL2/CD158k
Monoclonal
DyLight 350
50mM Sodium Borate
Mouse
Protein A or G purified from hybridoma culture supernatant
RUO
Primary
Human
Purified
Flow Cytometry, CyTOF
539304
Flow Cytometry, CyTOF-ready
killer cell immunoglobulin-like receptor 3DL2, CD158K, killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2, NKAT4, NKAT-4, NKAT4B, p140
BaF3 mouse pro-B cell line transfected with human KIR3DL2/CD158k, Accession # P43630
0.1 mL
Immunology
3812
Store at 4°C in the dark.
IgG1
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.